Exploration of Flavonoids to identify Potential Therapeutic Compounds by Targeting the Non-Structural V protein of Nipah Virus
Ahmad, S. R.; Zeyaullah, M.; AlShahrani, A. M.; Khan, M. S.; Ali, H.; Muzammil, K.; Mohieldin, A.; AG Altijani, A.; Dawria, A.; Mohamed, A. O. A.; Kalam, A.
Show abstract
Researchers are interested in a number of interdisciplinary approaches that might speed up and reduce the cost of creating new medications. This work aims to determine target proteins and choose a lead medication to combat the Nipah Virus. Following a study of the literature, we discover the non-structural V protein (UniProt ID: Q997F2). I-TASSER was used to estimate the 3D structure. We examined the flavonoid dataset in search of a strong inhibitor. Pyrx is used to use AutoDock Vina for docking. The interactions between the drug and the target protein binding were examined using BIOVIA Discovery Studio. Desmonds Molecular Dynamics Simulation (MD simulation) was used to study the stability of protein and inhibitor complexes in a physiological environment. Based on our research, we have designed two lead compounds that lessen the viruss effect. This discovery will benefit science as it may lead to the development of novel medications. The newly discovered natural compounds showed promise as inhibitors, showing less adverse effects and more efficiency.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling 98%
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 97%
- Investigating the role of N-terminal domain in phosphodiesterase 4B-inhibition by molecular dynamics simulation 97%
Similar papers in this journal
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 98%
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 98%
- Antivirals for Monkeypox Virus: Proposing an Effective Machine/Deep Learning Framework 97%
Similar papers in this journal
- Machine learning prediction of antiviral-HPV protein interactions for anti-HPV pharmacotherapy 96%
- Mechanistic insights into the Japanese Encephalitis Virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica 96%
- Mechanistic insights into the deleterious role of nasu-hakola disease associated TREM2 variants 96%
Similar papers in this journal
- Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design 98%
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 97%
- Cyclodextrin Derivative Enhances The Ophthalmic Delivery Of Poorly Soluble Azithromycin. 94%
Similar papers in this journal
- Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity 97%
- Elucidation of Structural Mechanism of ATP Inhibition at the AAA1 Subunit of Cytoplasmic Dynein 1 Using a Chemical "Toolkit" 96%
- Effect of Delta and Omicron mutations on the RBD-SD1 do-main of the Spike protein in SARS-CoV-2 and the Omicron mutations on RBD-ACE2 interface complex 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.